Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Provention Bio stock
Learn how to easily invest in Provention Bio stock.
Provention Bio is a biotechnology business based in the US. Provention Bio shares (PRVB) are listed on the NASDAQ and all prices are listed in US Dollars. Provention Bio employs 82 staff and has a trailing 12-month revenue of around $2.8 million.
How to buy Provention Bio stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – PRVB. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with low fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Provention Bio stock price (NASDAQ: PRVB)Use our graph to track the performance of PRVB stocks over time.
Provention Bio shares at a glance
|Latest market close||$9.10|
|52-week range||$3.19 - $10.88|
|50-day moving average||$9.21|
|200-day moving average||$6.08|
|Wall St. target price||$19.71|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.64|
Buy Provention Bio stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Provention Bio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Provention Bio price performance over time
|1 week (2023-01-27)||3.76%|
|1 month (2023-01-04)||-4.31%|
|3 months (2022-11-04)||23.31%|
|6 months (2022-08-04)||112.62%|
|1 year (2022-02-04)||74.00%|
|2 years (2021-02-04)||-38.64%|
|3 years (2020-02-04)||14.99|
|5 years (2018-01-31)||N/A|
Provention Bio financials
|Revenue TTM||$2.8 million|
|Gross profit TTM||$-68,232,000|
|Return on assets TTM||-40.46%|
|Return on equity TTM||-76.1%|
|Market capitalisation||$793.4 million|
TTM: trailing 12 months
Provention Bio share dividends
We're not expecting Provention Bio to pay a dividend over the next 12 months.
Provention Bio share price volatility
Over the last 12 months, Provention Bio's shares have ranged in value from as little as $3.185 up to $10.88. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Provention Bio's is 2.2885. This would suggest that Provention Bio's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Provention Bio overview
Provention Bio, Inc. , a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one diabetes (T1D); PRV-3279, which has completed Phase Ib clinical trial for the treatment of lupus; PRV-101, a coxsackie virus B (CVB) vaccine for the prevention of acute CVB infections and onset of T1D; and PRV-015, which is in phase IIb clinical trial for the treatment of gluten-free diet non-responding celiac disease. The company has a license and collaboration agreement with Amgen Inc. for PRV-015, a novel anti-IL-15 monoclonal antibody being developed for the treatment of gluten-free diet non-responsive celiac disease; and a strategic collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co. , Ltd. to develop and commercialize PRV-3279, a bispecific antibody-based molecule targeting the B cell surface proteins CD32B and CD79B in Greater China.
Provention Bio in the news
Provention Bio Announces the Grant of Inducement Awards
Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD®
Should You Invest in Provention Bio (PRVB)?
Frequently asked questionsWhat percentage of Provention Bio is owned by insiders or institutions?
Currently 6.056% of Provention Bio shares are held by insiders and 46.115% by institutions. How many people work for Provention Bio?
Latest data suggests 82 work at Provention Bio. When does the fiscal year end for Provention Bio?
Provention Bio's fiscal year ends in December. Where is Provention Bio based?
Provention Bio's address is: 55 Broad Street, Red Bank, NJ, United States, 07701 What is Provention Bio's ISIN number?
Provention Bio's international securities identification number is: US74374N1028 What is Provention Bio's CUSIP number?
Provention Bio's Committee on Uniform Securities Identification Procedures number is: 74374N102
More guides on Finder
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert